Zobrazeno 1 - 10
of 170
pro vyhledávání: '"Yoshiaki OGAWA"'
Autor:
Hidetsugu Kawai, Sawako Shiraiwa, Daisuke Ogiya, Masako Toyosaki, Shinichiro Machida, Rikio Suzuki, Makoto Onizuka, Yoshiaki Ogawa, Hiroshi Kawada
Publikováno v:
Leukemia Research Reports, Vol 22, Iss , Pp 100478- (2024)
The t(10;17)(p15;q21) translocation is a very rare recurrent cytogenetic aberration, and produced ZMYND11::MBTD1 fusion gene. To date, nine cases of acute leukemia with the t(10;17)(p15;q21) translocation have been reported, but the case of AML with
Externí odkaz:
https://doaj.org/article/898cfaa47ad54b6f9b8a5ac5d1b811b3
Publikováno v:
Current Oncology, Vol 29, Iss 11, Pp 8529-8539 (2022)
The prognosis of patients with multiple myeloma (MM) has improved dramatically with the introduction of new therapeutic drugs, but the disease eventually becomes drug-resistant, following an intractable and incurable course. A myeloma niche (MM niche
Externí odkaz:
https://doaj.org/article/8da9013be34a4886b627cf9f360a63cc
Publikováno v:
Case Reports in Gastroenterology, Vol 13, Iss 2, Pp 336-341 (2019)
A 47-year-old woman visited Tokai University Hospital complaining of left cervical lymph node swelling in 2007. The laboratory data were almost normal except for slight anemia (Hgb 10.5 g/dL), elevation of serum soluble interleukin (IL)-2 receptor le
Externí odkaz:
https://doaj.org/article/82d52af1bcbd484ca13ae48ce4e8f7cb
Autor:
Hidetsugu Kawai, Hiromichi Matsushita, Ken Ohmachi, Minoru Kojima, Shinichiro Machida, Yoshiaki Ogawa, Hiroshi Kawada, Naoya Nakamura, Kiyoshi Ando
Publikováno v:
Leukemia Research Reports, Vol 5, Iss C, Pp 3-6 (2016)
Hepatosplenic T-cell lymphoma (HSTCL), a rare type of γδ T-cell lymphoma, is characterized by hepatosplenomegaly and cytopenias. It is associated with immunodeficiency and its age of onset is reportedly between the 20s and 30s. We herein report 4 J
Externí odkaz:
https://doaj.org/article/efede19e8a3848818bebe9cbfb4cca75
Autor:
Minoru Kojima, Daisuke Ogiya, Akifumi Ichiki, Ryujiro Hara, Jun Amaki, Hidetsugu Kawai, Hiroki Numata, Ai Sato, Mitsuki Miyamoto, Rikio Suzuki, Shinichiro Machida, Hiromichi Matsushita, Yoshiaki Ogawa, Hiroshi Kawada, Kiyoshi Ando
Publikováno v:
Leukemia Research Reports, Vol 5, Iss C, Pp 11-13 (2016)
A 40-year-old male developed refractory acute promyelocytic leukemia (APL) after various treatments including all-trans retinoic acid, tamibarotene, arsenic trioxide (As2O3), conventional chemotherapy, and autologous peripheral blood stem cell transp
Externí odkaz:
https://doaj.org/article/173e03a47bf64722a7829c5b291bf530
Autor:
Rikio Suzuki, Hiromochi Matsushita, Hidetsugu Kawai, Hideyuki Matsuzawa, Kosuke Tsuboi, Shigeki Watanabe, Hiroshi Kawada, Yoshiaki Ogawa, Kiyoshi Ando
Publikováno v:
Leukemia Research Reports, Vol 3, Iss 2, Pp 54-57 (2014)
T-cell prolymphocytic leukemia (T-PLL), a rare type of peripheral T-cell leukemia, is characterized by marked splenomegaly with rapidly progressive lymphocytosis and a poor prognosis. Nine kinds of ABL1 chimeric genes have been identified in various
Externí odkaz:
https://doaj.org/article/19c3cd0ba32f46eeaf92e394041b8393
Publikováno v:
Energies, Vol 9, Iss 8, p 658 (2016)
Polymer electrolyte membranes (PEMs) for direct methanol fuel cell (DMFC) applications were prepared from a graft-copolymer (PSF-g-PSSA) consisting of a polysulfone (PSF) main chain and poly(styrene sulfonic acid) (PSSA) side chains with various aver
Externí odkaz:
https://doaj.org/article/1d22114414254859b59eff4b49afd235
Autor:
Yukari Muguruma, Hiromichi Matsushita, Takashi Yahata, Shizu Yumino, Yumiko Tanaka, Hayato Miyachi, Yoshiaki Ogawa, Hiroshi Kawada, Mamoru Ito, Kiyoshi Ando
Publikováno v:
Haematologica, Vol 96, Iss 4 (2011)
Background To understand how myelodysplastic syndrome cells evolve from normal stem cells and gain competitive advantages over normal hematopoiesis, we established a murine xenograft model harboring bone marrow cells from patients with myelodysplasti
Externí odkaz:
https://doaj.org/article/2578e17e98824a53a4a038756aa51a48
Publikováno v:
International Journal of Hematology. 115:233-243
RAS/RAF/MEK/ERK pathway inhibitors exhibit significant anti-tumor effects against various tumor types, including multiple myeloma (MM), and they are predicted to play a pivotal role in precision medicine. The XPO1 inhibitor KPT-330 has also exhibited
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e7265408be9f11d17e88cc3f00cdca76
https://doi.org/10.1007/s12185-021-03244-1
https://doi.org/10.1007/s12185-021-03244-1
Autor:
Makoto Onizuka, Hiromichi Matsushita, Ryujiro Hara, Sawako Shiraiwa, Ken Ohmachi, Daisuke Ogiya, Masako Toyosaki, Yoshiaki Ogawa, Hiroshi Kawada, Yasuyuki Aoyama, Eri Kikkawa, Kaito Harada, Rikio Suzuki, Kiyoshi Ando, Sinichiro Machida
Publikováno v:
Annals of Hematology. 100:2479-2486
The prognosis of Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph + ALL) has improved dramatically. Although measurable residual disease (MRD) kinetics during pretransplant treatment has been recently reported to correlate with patie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d32c8d7a3901a8dca17b39f93e4bb83
https://doi.org/10.1007/s00277-021-04587-9
https://doi.org/10.1007/s00277-021-04587-9